362 related articles for article (PubMed ID: 16432143)
1. Inflammatory, immune, and viral aspects of inclusion-body myositis.
Dalakas MC
Neurology; 2006 Jan; 66(2 Suppl 1):S33-8. PubMed ID: 16432143
[TBL] [Abstract][Full Text] [Related]
2. Understanding the immunopathogenesis of inclusion-body myositis: present and future prospects.
Dalakas MC
Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):948-58. PubMed ID: 12407303
[TBL] [Abstract][Full Text] [Related]
3. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis.
Dimitri D; Benveniste O; Dubourg O; Maisonobe T; Eymard B; Amoura Z; Jean L; Tiev K; Piette JC; Klatzmann D; Herson S; Boyer O
Brain; 2006 Apr; 129(Pt 4):986-95. PubMed ID: 16455793
[TBL] [Abstract][Full Text] [Related]
4. Sporadic inclusion body myositis: a continuing puzzle.
Needham M; Mastaglia FL
Neuromuscul Disord; 2008 Jan; 18(1):6-16. PubMed ID: 18160291
[TBL] [Abstract][Full Text] [Related]
5. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
Schmidt J; Rakocevic G; Raju R; Dalakas MC
Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591
[TBL] [Abstract][Full Text] [Related]
6. Inclusion body myositis with human immunodeficiency virus infection: four cases with clonal expansion of viral-specific T cells.
Dalakas MC; Rakocevic G; Shatunov A; Goldfarb L; Raju R; Salajegheh M
Ann Neurol; 2007 May; 61(5):466-75. PubMed ID: 17366634
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory muscle diseases: a critical review on pathogenesis and therapies.
Dalakas MC
Curr Opin Pharmacol; 2010 Jun; 10(3):346-52. PubMed ID: 20409756
[TBL] [Abstract][Full Text] [Related]
8. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
Chahin N; Engel AG
Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720
[TBL] [Abstract][Full Text] [Related]
9. CCR7+ myeloid dendritic cells together with CCR7+ T cells and CCR7+ macrophages invade CCL19+ nonnecrotic muscle fibers in inclusion body myositis.
Tateyama M; Fujihara K; Misu T; Itoyama Y
J Neurol Sci; 2009 Apr; 279(1-2):47-52. PubMed ID: 19171354
[TBL] [Abstract][Full Text] [Related]
10. Cellular mechanisms in inflammatory myopathies.
Hohlfeld R; Goebels N; Engel AG
Baillieres Clin Neurol; 1993 Nov; 2(3):617-35. PubMed ID: 8156145
[TBL] [Abstract][Full Text] [Related]
11. Treatment of inclusion body myositis.
Cherin P
Curr Opin Rheumatol; 1999 Nov; 11(6):456-61. PubMed ID: 10551668
[TBL] [Abstract][Full Text] [Related]
12. Update on idiopathic inflammatory myopathies.
Briani C; Doria A; Sarzi-Puttini P; Dalakas MC
Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
Dalakas MC
Curr Opin Neurol; 2004 Oct; 17(5):561-7. PubMed ID: 15367860
[TBL] [Abstract][Full Text] [Related]
14. Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies.
Dalakas MC
Nat Clin Pract Neurol; 2006 Aug; 2(8):437-47. PubMed ID: 16932602
[TBL] [Abstract][Full Text] [Related]
15. Review: An update on inflammatory and autoimmune myopathies.
Dalakas MC
Neuropathol Appl Neurobiol; 2011 Apr; 37(3):226-42. PubMed ID: 21155862
[TBL] [Abstract][Full Text] [Related]
16. Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies.
Amemiya K; Granger RP; Dalakas MC
Brain; 2000 Oct; 123 ( Pt 10)():2030-9. PubMed ID: 11004120
[TBL] [Abstract][Full Text] [Related]
17. Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy.
Askanas V; Engel WK; Yang CC; Alvarez RB; Lee VM; Wisniewski T
Am J Pathol; 1998 Apr; 152(4):889-95. PubMed ID: 9546349
[TBL] [Abstract][Full Text] [Related]
18. Sporadic inclusion body myositis: counts of different types of abnormal fibers.
Pruitt JN; Showalter CJ; Engel AG
Ann Neurol; 1996 Jan; 39(1):139-43. PubMed ID: 8572661
[TBL] [Abstract][Full Text] [Related]
19. Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis.
Lünemann JD; Schmidt J; Schmid D; Barthel K; Wrede A; Dalakas MC; Münz C
Ann Neurol; 2007 May; 61(5):476-83. PubMed ID: 17469125
[TBL] [Abstract][Full Text] [Related]
20. The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype.
Rojana-udomsart A; Needham M; Luo YB; Fabian V; Walters S; Zilko PJ; Mastaglia FL
Clin Neurol Neurosurg; 2011 Sep; 113(7):559-63. PubMed ID: 21507567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
